. Author manuscript; available in PMC: 2018 Feb 1.

Published in final edited form as: Mindfulness (N Y). 2016 Aug 4;8(1):126–135. doi: 10.1007/s12671-016-0586-9

Table 3.

Stimulant use and negative affect outcomes as a function of treatment condition.

		Baseline (n=63)	Week 12 (n=43)	Week 16 (n=44)
N (%) stimulant free UDS
Overall sample		41 (65.0%)	28 (64.1%)	26 (59.1%)
MBRP
	Individuals with Major Depressive Disorder	62.1%	87.5%	100%
	Individuals with Generalized Anxiety Disorder	40.0%	66.6%	96.0%
Health ED
	Individuals with Major Depressive Disorder	60.0%	62.5%	50.0%
	Individuals with Generalized Anxiety Disorder	33.3%	33.3%	60.0%
Secondary outcomes M(SD)
Depression (BDI)
	Overall sample	15.1 (11.5)	8.7 (11.2)	6.8 (7.9)
	MBRP (49.2%)	14.5 (9.6)	5.3 (7.2)	4.7 (6.9)
	Health Ed (50.8%)	15.6 (12.9)	12.0 (13.4)	9.0 (8.5)
Anxiety (BAI)
	Overall sample	9.8 (9.1)	6.8 (11.8)	5.9 (9.2)
	MBRP(49.2%)	9.1 (8.7)	5.2 (9.2)	3.2 (7.4)
	Health Ed (50.8%)	10.4 (9.6)	8.3 (13.9)	9.0 (10.2)